We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. Our first molecule, PHA121, is a novel, small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema, or HAE. Bradykinin-B2-receptor inhibition is a clinically validated mechani® for the treatment of HAE, as demonstrated by icatibant, which is a bradykinin B2-receptor antagonist approved in Europe in 2008 and in the United States in 2011 (as FIRAZYR).
Market Cap | 693.713 Million | Shares Outstanding | 33.129 Million | Avg 30-day Volume | 39.938 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -63.587 Million |
Price to Book Value | 1.4136 | Operating Margin | 0.0 | Enterprise Value | 44.924 Million |
Current Ratio | 118.706 | EPS Growth | -2.229 | Quick Ratio | 118.706 |
1 Yr BETA | -0.0459 | 52-week High/Low | 27.5 / 13.14 | Profit Margin | 0.0 |
Operating Cash Flow Growth | 417.6796 | Altman Z-Score | 14.1243 | Free Cash Flow to Firm | -41.063 Million |
Earnings Report | 2022-07-29 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
PHARVARIS NV PHVS | 2022-06-24 22:15:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 21:45:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 21:15:04 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 20:45:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 20:15:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 19:45:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 19:15:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 18:45:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 18:15:04 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 17:45:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 17:15:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 16:45:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 16:15:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 15:45:03 UTC | -67.7315 | 69.3015 | 4000 |
PHARVARIS NV PHVS | 2022-06-24 15:15:03 UTC | -67.7315 | 69.3015 | 200 |
PHARVARIS NV PHVS | 2022-06-24 14:45:03 UTC | -67.7315 | 69.3015 | 200 |
PHARVARIS NV PHVS | 2022-06-24 14:15:03 UTC | -67.7315 | 69.3015 | 200 |
PHARVARIS NV PHVS | 2022-06-24 13:45:03 UTC | -67.7315 | 69.3015 | 200 |
PHARVARIS NV PHVS | 2022-06-24 13:15:03 UTC | -67.7315 | 69.3015 | 200 |
PHARVARIS NV PHVS | 2022-06-24 12:45:03 UTC | -67.7315 | 69.3015 | 200 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|